Synthyra

kcat

Oracle

Estimates enzyme turnover potential from protein sequence.

  • enzyme
  • kinetics

kcat

kcat provides a first-pass sequence-based signal for enzyme turnover potential.

What It Does

The oracle helps compare enzymes and variants when catalytic throughput is a key design or screening objective.

Why It Matters

Enzyme campaigns often need to decide which variants deserve kinetic characterization. A turnover-oriented signal can help rank candidates before expensive assays.

Intended Use

Use kcat for early enzyme triage, variant ranking, and prioritization of candidates for kinetic measurement.

Limitations

kcat is substrate-specific and condition-specific. Sequence alone cannot capture substrate identity, cofactors, pH, temperature, expression quality, or assay format. Treat predictions as hypotheses for experimental prioritization.

Try kcat

Run predictions with this model through the Synthyra platform.

Related Models

Atlas Oracle Suite

Oracle

A set of fast protein property predictors for triaging sequence quality, function, localization, and developability.

EC General

Oracle

Suggests broad enzyme-class hypotheses from protein sequence.

EC Rigor

Oracle

Provides stricter enzyme-function hypotheses when higher-confidence EC assignment is needed.

Related News

August 21, 2025

Protify: Model Choice As An Experiment

Across 32 protein tasks, 13 different models won at least once and none of the wins were statistically significant. Picking a protein language model is an experiment, not a preference.

July 30, 2024

Annotation Vocabulary: Teaching Protein Models the Language of Function

Replace free-text protein descriptions with a vocabulary of ontology terms, and a model trained for three dollars in compute produces better functional embeddings than models a thousand times its cost.

Synthyra

Optimize the outcome, not the interface.

Biological design programs selected on the predicted state of the system, not the quality of one contact.

Platform

DiscoverDemosModelsAPI

Company

NewsOur VisionTeamContactOpen sourceSign in

© 2026 Synthyra. All rights reserved.

TermsPrivacy